@article{41dc2e06be6147e19e4679f470c7fa42,
title = "Genotype-guided treatment of oral P2Y(12) inhibitors: where do we stand?",
keywords = "acute coronary syndrome, clopidogrel, CYP2C19, genotype-guided, myocardial infarction, P2Y12 inhibitor, prasugrel, ticagrelor, ANTIPLATELET TREATMENT, CYP2C19 GENOTYPE, TASK-FORCE, CLOPIDOGREL, GUIDELINES, MANAGEMENT, THERAPY",
author = "Claassens, {Daniel M. F.} and {ten Berg}, {Jurrien M.}",
year = "2020",
doi = "10.2217/pgs-2019-0162",
language = "English",
volume = "21",
pages = "83--86",
journal = "Pharmacogenomics",
issn = "1462-2416",
publisher = "FUTURE MEDICINE LTD",
number = "2",
}